Hong Ling
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hong Ling has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
Guangxin Xing
Department of Biochemistry University of Western Ontario London Canada
7 shared publicationsKevin N. Kirouac
Department of Biochemistry, University of Western Ontario, London, Ontario, Canada N6A 5C1
5 shared publicationsVikash Jha
Department of Biochemistry, Schulich School of Medicine & Dentistry, University of Western Ontario, London, Ontario, N6A 5C1, Canada
5 shared publications- Sam Siu Hang Chu
Department of Biochemistry, University of Western Ontario, London, Ontario, Canada, N6A 5C1
4 shared publications Ashis K. Basu
Department of Chemistry, University of Connecticut, Storrs, CT 06269, USA
2 shared publications- Guangxin Xing
Department of Biochemistry, University of Western Ontario, London, Ontario, Canada, N6A 5C1
2 shared publications
Latest Publications
- Open Access
- 3 August 2026
- Published by Wiley in The FEBS Journal
The trimeric Shu complex in C. elegans is an ATPase that remodels RAD51 filaments in the homologous recombination‐associated DNA damage response
Homologous recombination (HR) is critical for error‐free lesion bypass. This error‐free lesion tolerance pathway is initiated by the RAD51 recombinase, which forms nucleoprotein filaments on single‐stranded DNA (ssDNA) to facilitate template‐directed repair using homologous sister chromatids. RAD51 filaments are tightly regulated by RAD51 mediator proteins. As such mediators, Shu complexes facilitate HR‐directed DNA damage tolerance and are evolutionarily conserved from yeast to humans. The Caenorhabditis elegans ( C . elegans ) Shu complex is a heterotrimer consisting of three protein subunits: RFS‐1, RIP‐1, and SWS‐1. However, the biochemical properties of this trimeric complex remain unclear. Here, we report the biochemical characterization of the C . elegans Shu complex and interactions with DNA, ATP, and RAD‐51 filaments. We first revealed that the Shu trimer preferentially binds DNA with an exposed 5′ end, particularly favoring a fork‐shaped double‐stranded DNA (dsDNA). Then, we found that the RFS‐1/RIP‐1/SWS‐1 trimer binds to ATP and exhibits DNA‐dependent ATPase activity. Through site‐specific mutagenesis, we identified the catalytic residues in the RFS‐1 domain and validated the ATPase activity. Using fluorescence‐based assays, we further demonstrated that the Shu trimer remodels RAD‐51 filaments in an ATP‐hydrolysis‐dependent manner and stabilizes the filaments in an ATP‐binding‐dependent manner. Using CRISPR‐Cas9‐induced disruption of the Walker motif in rfs‐1 , we demonstrate that the ATPase activity of the C . elegans Shu complex is critical for organismal survival under camptothecin‐induced genotoxic stress. These findings provide key mechanistic insights into how the C . elegans Shu complex regulates RAD‐51 filament dynamics and primes the filaments for downstream HR‐mediated DNA repair processes.
- 3 August 2026
- Published by Wiley in The FEBS Journal
Open AccessThe trimeric Shu complex in C. elegans is an ATPase that remodels RAD51 filaments in the homologous recombination‐associated DNA damage response
Homologous recombination (HR) is critical for error‐free lesion bypass. This error‐free lesion tolerance pathway is initiated by the RAD51 recombinase, which forms nucleoprotein filaments on single‐stranded DNA (ssDNA) to facilitate template‐directed repair using homologous sister chromatids. RAD51 filaments are tightly regulated by RAD51 mediator proteins. As such mediators, Shu complexes facilitate HR‐directed DNA damage tolerance and are evolutionarily conserved from yeast to humans. The Caenorhabditis elegans ( C . elegans ) Shu complex is a heterotrimer consisting of three protein subunits: RFS‐1, RIP‐1, and SWS‐1. However, the biochemical properties of this trimeric complex remain unclear. Here, we report the biochemical characterization of the C . elegans Shu complex and interactions with DNA, ATP, and RAD‐51 filaments. We first revealed that the Shu trimer preferentially binds DNA with an exposed 5′ end, particularly favoring a fork‐shaped double‐stranded DNA (dsDNA). Then, we found that the RFS‐1/RIP‐1/SWS‐1 trimer binds to ATP and exhibits DNA‐dependent ATPase activity. Through site‐specific mutagenesis, we identified the catalytic residues in the RFS‐1 domain and validated the ATPase activity. Using fluorescence‐based assays, we further demonstrated that the Shu trimer remodels RAD‐51 filaments in an ATP‐hydrolysis‐dependent manner and stabilizes the filaments in an ATP‐binding‐dependent manner. Using CRISPR‐Cas9‐induced disruption of the Walker motif in rfs‐1 , we demonstrate that the ATPase activity of the C . elegans Shu complex is critical for organismal survival under camptothecin‐induced genotoxic stress. These findings provide key mechanistic insights into how the C . elegans Shu complex regulates RAD‐51 filament dynamics and primes the filaments for downstream HR‐mediated DNA repair processes.
- Open Access
The trimeric Shu complex in C. elegans is an ATPase that remodels RAD51 filaments in the homologous recombination-associated DNA damage response
Homologous recombination (HR) is critical to error-free lesion bypass in the DNA damage response. This error-free lesion tolerance pathway is initiated by the RAD51 recombinase, which forms nucleoprotein filaments on single-stranded DNA (ssDNA) to facilitate template-directed repair using homologous sister chromatids. RAD51 filaments are tightly regulated by RAD51 mediator proteins. Among these, the Shu complexes facilitate HR-directed DNA damage tolerance and are evolutionarily conserved from yeast to humans. The Caenorhabditis elegans Shu complex is a heterotrimer consisting of three protein subunits: RFS1, RIP1, and SWS1. However, the biochemical properties of this trimeric complex remain unclear. Here, we report the biochemical characterization of the C . elegans Shu complex and interactions with DNA, ATP, and Rad51 filaments. We first revealed that the Shu trimer preferentially binds DNA with an exposed 5′ end, particularly favoring a fork-shaped double-stranded DNA (dsDNA). Then, we found that the trimer binds to ATP and exhibits DNA-dependent ATPase activity. Through site-specific mutagenesis, we identified the catalytic residues in the RFS1 domain and validated the ATPase activity. Using fluorescence-based assays, we further demonstrated that the Shu trimer remodels RAD51 filaments in an ATP-hydrolysis-dependent manner and stabilizes the filaments in an ATP-binding-dependent manner. These findings provide key mechanistic insights into how the C . elegans Shu complex regulates RAD51 filaments, priming them for downstream HR-mediated DNA repair processes.
Open AccessThe trimeric Shu complex in C. elegans is an ATPase that remodels RAD51 filaments in the homologous recombination-associated DNA damage response
Homologous recombination (HR) is critical to error-free lesion bypass in the DNA damage response. This error-free lesion tolerance pathway is initiated by the RAD51 recombinase, which forms nucleoprotein filaments on single-stranded DNA (ssDNA) to facilitate template-directed repair using homologous sister chromatids. RAD51 filaments are tightly regulated by RAD51 mediator proteins. Among these, the Shu complexes facilitate HR-directed DNA damage tolerance and are evolutionarily conserved from yeast to humans. The Caenorhabditis elegans Shu complex is a heterotrimer consisting of three protein subunits: RFS1, RIP1, and SWS1. However, the biochemical properties of this trimeric complex remain unclear. Here, we report the biochemical characterization of the C . elegans Shu complex and interactions with DNA, ATP, and Rad51 filaments. We first revealed that the Shu trimer preferentially binds DNA with an exposed 5′ end, particularly favoring a fork-shaped double-stranded DNA (dsDNA). Then, we found that the trimer binds to ATP and exhibits DNA-dependent ATPase activity. Through site-specific mutagenesis, we identified the catalytic residues in the RFS1 domain and validated the ATPase activity. Using fluorescence-based assays, we further demonstrated that the Shu trimer remodels RAD51 filaments in an ATP-hydrolysis-dependent manner and stabilizes the filaments in an ATP-binding-dependent manner. These findings provide key mechanistic insights into how the C . elegans Shu complex regulates RAD51 filaments, priming them for downstream HR-mediated DNA repair processes.
- Open Access
- 8 May 2025
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (6) , 110212
The role of human Shu complex in ATP-dependent regulation of RAD51 filaments during homologous recombination–associated DNA damage response
- 8 May 2025
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (6) , 110212
Open AccessThe role of human Shu complex in ATP-dependent regulation of RAD51 filaments during homologous recombination–associated DNA damage response
- Open Access
- 29 November 2024
- Published by Elsevier in DNA Repair
- Vol. 145, 103792
The Shu complex is an ATPase that regulates Rad51 filaments during homologous recombination in the DNA damage response
- 29 November 2024
- Published by Elsevier in DNA Repair
- Vol. 145, 103792
Open AccessThe Shu complex is an ATPase that regulates Rad51 filaments during homologous recombination in the DNA damage response
- Open Access
Shu complex is an ATPase that regulates Rad51 filaments in homologous recombination-directed DNA damage response
Rad51 filaments are Rad51-coated single-stranded DNA and essential intermediates in homologous recombination (HR) and the HR-associated DNA damage response. The yeast Shu complex (Shu) is a conserved regulator of HR, working through its modulation of Rad51 filaments. However, the biochemical properties of Shu remain unclear, which hinders molecular insight into Shu’s role in HR and the DNA damage response. In this work, we biochemically characterized Shu and analyzed its molecular actions on single-stranded DNA and Rad51 filaments. First, we revealed that Shu preferentially binds DNA with ssDNA components and ssDNA/double-stranded DNA junctions. Then, we identified and validated, through site-specific mutagenesis, that Shu is an ATPase and hydrolyzes ATP in a DNA-dependent manner. Furthermore, we showed that Shu interacts with ssDNA and Rad51 filaments at the 5’ end preferentially, altering the conformations of ssDNA and the filaments. The alterations depend on the ATP hydrolysis of Shu, suggesting that the ATPase activity of Shu is important in regulating its functions in HR. The preference of Shu for acting on the 5’ end of Rad51 filaments aligns with the observation that Shu promotes lesion bypass at the lagging strand of a replication fork. Our work on Shu, a prototype modulator of Rad51 filaments in eukaryotes, provides a general molecular mechanism for Rad51-mediated error-free DNA lesion bypass.
Open AccessShu complex is an ATPase that regulates Rad51 filaments in homologous recombination-directed DNA damage response
Rad51 filaments are Rad51-coated single-stranded DNA and essential intermediates in homologous recombination (HR) and the HR-associated DNA damage response. The yeast Shu complex (Shu) is a conserved regulator of HR, working through its modulation of Rad51 filaments. However, the biochemical properties of Shu remain unclear, which hinders molecular insight into Shu’s role in HR and the DNA damage response. In this work, we biochemically characterized Shu and analyzed its molecular actions on single-stranded DNA and Rad51 filaments. First, we revealed that Shu preferentially binds DNA with ssDNA components and ssDNA/double-stranded DNA junctions. Then, we identified and validated, through site-specific mutagenesis, that Shu is an ATPase and hydrolyzes ATP in a DNA-dependent manner. Furthermore, we showed that Shu interacts with ssDNA and Rad51 filaments at the 5’ end preferentially, altering the conformations of ssDNA and the filaments. The alterations depend on the ATP hydrolysis of Shu, suggesting that the ATPase activity of Shu is important in regulating its functions in HR. The preference of Shu for acting on the 5’ end of Rad51 filaments aligns with the observation that Shu promotes lesion bypass at the lagging strand of a replication fork. Our work on Shu, a prototype modulator of Rad51 filaments in eukaryotes, provides a general molecular mechanism for Rad51-mediated error-free DNA lesion bypass.
- Open Access
- 3 June 2023
- Published by MDPI AG in Pharmaceuticals
- Vol. 16 (6) , 837
Annexin A5 Inhibits Endothelial Inflammation Induced by Lipopolysaccharide-Activated Platelets and Microvesicles via Phosphatidylserine Binding
Sepsis is caused by a dysregulated immune response to infection and is a leading cause of mortality globally. To date, no specific therapeutics are available to treat the underlying septic response. We and others have shown that recombinant human annexin A5 (Anx5) treatment inhibits pro-inflammatory cytokine production and improves survival in rodent sepsis models. During sepsis, activated platelets release microvesicles (MVs) with externalization of phosphatidylserine to which Anx5 binds with high affinity. We hypothesized that recombinant human Anx5 blocks the pro-inflammatory response induced by activated platelets and MVs in vascular endothelial cells under septic conditions via phosphatidylserine binding. Our data show that treatment with wildtype Anx5 reduced the expression of inflammatory cytokines and adhesion molecules induced by lipopolysaccharide (LPS)-activated platelets or MVs in endothelial cells (p < 0.01), which was not observed with Anx5 mutant deficient in phosphatidylserine binding. In addition, wildtype Anx5 treatment, but not Anx5 mutant, improved trans-endothelial electrical resistance (p < 0.05) and reduced monocyte (p < 0.001) and platelet (p < 0.001) adhesion to vascular endothelial cells in septic conditions. In conclusion, recombinant human Anx5 inhibits endothelial inflammation induced by activated platelets and MVs in septic conditions via phosphatidylserine binding, which may contribute to its anti-inflammatory effects in the treatment of sepsis.
- 3 June 2023
- Published by MDPI AG in Pharmaceuticals
- Vol. 16 (6) , 837
Open AccessAnnexin A5 Inhibits Endothelial Inflammation Induced by Lipopolysaccharide-Activated Platelets and Microvesicles via Phosphatidylserine Binding
Sepsis is caused by a dysregulated immune response to infection and is a leading cause of mortality globally. To date, no specific therapeutics are available to treat the underlying septic response. We and others have shown that recombinant human annexin A5 (Anx5) treatment inhibits pro-inflammatory cytokine production and improves survival in rodent sepsis models. During sepsis, activated platelets release microvesicles (MVs) with externalization of phosphatidylserine to which Anx5 binds with high affinity. We hypothesized that recombinant human Anx5 blocks the pro-inflammatory response induced by activated platelets and MVs in vascular endothelial cells under septic conditions via phosphatidylserine binding. Our data show that treatment with wildtype Anx5 reduced the expression of inflammatory cytokines and adhesion molecules induced by lipopolysaccharide (LPS)-activated platelets or MVs in endothelial cells (p < 0.01), which was not observed with Anx5 mutant deficient in phosphatidylserine binding. In addition, wildtype Anx5 treatment, but not Anx5 mutant, improved trans-endothelial electrical resistance (p < 0.05) and reduced monocyte (p < 0.001) and platelet (p < 0.001) adhesion to vascular endothelial cells in septic conditions. In conclusion, recombinant human Anx5 inhibits endothelial inflammation induced by activated platelets and MVs in septic conditions via phosphatidylserine binding, which may contribute to its anti-inflammatory effects in the treatment of sepsis.
- Open Access
- 11 October 2018
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 15125
2.0 Å resolution crystal structure of human polκ reveals a new catalytic function of N-clasp in DNA replication
Human polymerase kappa (polκ) is a distinct Y-family DNA polymerase with a unique N-terminal N-clasp domain. The N-clasp renders polκ’s high efficiency and accuracy in DNA replication and lesion bypass. How N-clasp empowers polκ in replication remains unclear due to the disordering of N-clasp. Here, we present a 2.0-Å resolution crystal structure of a polκ ternary complex with DNA and an incoming nucleotide. The structure-function study reveals an ordered N-clasp domain that brings conserved and functionally important residues in contact with the replicating basepair in the active site and contributes to the nucleotidyl transfer reaction. Particularly, a fully ordered Lys25 from the N-clasp domain is in H-bonding with the α- and γ-phosphates of the incoming nucleotide. K25A mutation reduces the polymerase activity of polκ significantly. This lysine is structurally analogous to a conserved lysine in the A-family DNA polymerases in the closed form. In contrast, Lys25 in the previous structures of polκ does not have any contacts with the incoming nucleotide, resembling an open form of a DNA polymerase. Based on structural and functional similarity, we propose a local open/closed mechanism for polκ in DNA replication catalysis, which mimics the common mechanism for all DNA polymerases.
- 11 October 2018
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 15125
Open Access2.0 Å resolution crystal structure of human polκ reveals a new catalytic function of N-clasp in DNA replication
Human polymerase kappa (polκ) is a distinct Y-family DNA polymerase with a unique N-terminal N-clasp domain. The N-clasp renders polκ’s high efficiency and accuracy in DNA replication and lesion bypass. How N-clasp empowers polκ in replication remains unclear due to the disordering of N-clasp. Here, we present a 2.0-Å resolution crystal structure of a polκ ternary complex with DNA and an incoming nucleotide. The structure-function study reveals an ordered N-clasp domain that brings conserved and functionally important residues in contact with the replicating basepair in the active site and contributes to the nucleotidyl transfer reaction. Particularly, a fully ordered Lys25 from the N-clasp domain is in H-bonding with the α- and γ-phosphates of the incoming nucleotide. K25A mutation reduces the polymerase activity of polκ significantly. This lysine is structurally analogous to a conserved lysine in the A-family DNA polymerases in the closed form. In contrast, Lys25 in the previous structures of polκ does not have any contacts with the incoming nucleotide, resembling an open form of a DNA polymerase. Based on structural and functional similarity, we propose a local open/closed mechanism for polκ in DNA replication catalysis, which mimics the common mechanism for all DNA polymerases.
- 1 May 2018
- Published by Elsevier in Journal of Molecular Biology
- Vol. 430 (11) , 1577-1589
Structural Basis for Human DNA Polymerase Kappa to Bypass Cisplatin Intrastrand Cross-Link (Pt-GG) Lesion as an Efficient and Accurate Extender
- 1 May 2018
- Published by Elsevier in Journal of Molecular Biology
- Vol. 430 (11) , 1577-1589
Structural Basis for Human DNA Polymerase Kappa to Bypass Cisplatin Intrastrand Cross-Link (Pt-GG) Lesion as an Efficient and Accurate Extender
- 23 October 2017
- Published by American Chemical Society (ACS) in Chemical Research in Toxicology
- Vol. 30 (11) , 2023-2032
Mechanism of Error-Free DNA Replication Past Lucidin-Derived DNA Damage by Human DNA Polymerase κ
DNA damage impinges on genetic information flow and has significant implications in human disease and aging. Lucidin-3-O-primeveroside (LuP) is an anthraquinone derivative present in madder root, which has been used as a coloring agent and food additive. LuP can be metabolically converted to genotoxic compound lucidin, which subsequently forms lucidin-specific N2-2′-deoxyguanosine (N2-dG) and N6-2′-deoxyadenosine (N6-dA) DNA adducts. Lucidin is mutagenic and carcinogenic in rodents but has low carcinogenic risks in humans. To understand the molecular mechanism of low carcinogenicity of lucidin in humans, we performed DNA replication assays using site-specifically modified oligodeoxynucleotides containing a structural analogue (LdG) of lucidin-N2-dG DNA adduct and determined the crystal structures of DNA polymerase (pol) κ in complex with LdG-bearing DNA and an incoming nucleotide. We examined four human pols (pol η, pol ι, pol κ, and Rev1) in their efficiency and accuracy during DNA replication with LdG; these pols are key players in translesion DNA synthesis. Our results demonstrate that pol κ efficiently and accurately replicates past the LdG adduct, whereas DNA replication by pol η, pol ι is compromised to different extents. Rev1 retains its ability to incorporate dCTP opposite the lesion albeit with decreased efficiency. Two ternary crystal structures of pol κ illustrate that the LdG adduct is accommodated by pol κ at the enzyme active site during insertion and postlesion-extension steps. The unique open active site of pol κ allows the adducted DNA to adopt a standard B-form for accurate DNA replication. Collectively, these biochemical and structural data provide mechanistic insights into the low carcinogenic risk of lucidin in humans.
- 23 October 2017
- Published by American Chemical Society (ACS) in Chemical Research in Toxicology
- Vol. 30 (11) , 2023-2032
Mechanism of Error-Free DNA Replication Past Lucidin-Derived DNA Damage by Human DNA Polymerase κ
DNA damage impinges on genetic information flow and has significant implications in human disease and aging. Lucidin-3-O-primeveroside (LuP) is an anthraquinone derivative present in madder root, which has been used as a coloring agent and food additive. LuP can be metabolically converted to genotoxic compound lucidin, which subsequently forms lucidin-specific N2-2′-deoxyguanosine (N2-dG) and N6-2′-deoxyadenosine (N6-dA) DNA adducts. Lucidin is mutagenic and carcinogenic in rodents but has low carcinogenic risks in humans. To understand the molecular mechanism of low carcinogenicity of lucidin in humans, we performed DNA replication assays using site-specifically modified oligodeoxynucleotides containing a structural analogue (LdG) of lucidin-N2-dG DNA adduct and determined the crystal structures of DNA polymerase (pol) κ in complex with LdG-bearing DNA and an incoming nucleotide. We examined four human pols (pol η, pol ι, pol κ, and Rev1) in their efficiency and accuracy during DNA replication with LdG; these pols are key players in translesion DNA synthesis. Our results demonstrate that pol κ efficiently and accurately replicates past the LdG adduct, whereas DNA replication by pol η, pol ι is compromised to different extents. Rev1 retains its ability to incorporate dCTP opposite the lesion albeit with decreased efficiency. Two ternary crystal structures of pol κ illustrate that the LdG adduct is accommodated by pol κ at the enzyme active site during insertion and postlesion-extension steps. The unique open active site of pol κ allows the adducted DNA to adopt a standard B-form for accurate DNA replication. Collectively, these biochemical and structural data provide mechanistic insights into the low carcinogenic risk of lucidin in humans.
- 1 January 2017
- Published by Elsevier in DNA Repair
- Vol. 49, 43-50
Structural basis of accurate replication beyond a bulky major benzo[a]pyrene adduct by human DNA polymerase kappa
- 1 January 2017
- Published by Elsevier in DNA Repair
- Vol. 49, 43-50
Structural basis of accurate replication beyond a bulky major benzo[a]pyrene adduct by human DNA polymerase kappa